| View |
|
DRP-11553-01
|
Phenytoin sodium
|
Surphen
|
50 mg / mL
|
Solution for Injection (IM/IV)
|
Antiepileptic (Hydantoin Derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
08 November 2023
|
29 March 2027
|
| View |
DRP-8463_PI_01.pdf
|
DRP-8463
|
Folic Acid
|
Prevena
|
5 mg
|
Capsule
|
-
|
San Marino Laboratories Corporation
|
Philippines
|
Automatic Renewal
|
23 March 2021
|
01 December 2025
|
| View |
|
DRP-9201-01
|
Cholecalciferol (Vit. D3)
|
Dynamic D3
|
3,000IU
|
Capsule
|
-
|
San Marino Laboratories Corporation
|
Philippines
|
Initial (CLIDP)
|
18 June 2021
|
18 October 2025
|
| View |
DR-XY47289_PI_01.pdf
|
DR-XY47289
|
Tadalafil
|
Caliberi
|
20 mg
|
Orodispersable Film
|
-
|
Pharmacostech Co.,Ltd
|
Korea
|
Release (Variation)
|
12 October 2023
|
31 May 2026
|
| View |
DR-XY47290_PI_01.pdf
|
DR-XY47290
|
Tadalafil
|
Caliberi
|
5 mg
|
Orodispersable Film
|
-
|
Pharmacostech Co.,Ltd
|
Korea
|
Release (Variation)
|
12 October 2023
|
31 May 2026
|
| View |
DRP-10557-01_PI_01.pdf
|
DRP-10557-01
|
Meropenem (as trihydrate)
|
Morfenexx 1000
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Mepromax Lifesciences Pvt. Ltd.
|
India
|
Automatic Renewal
|
29 March 2024
|
15 December 2029
|
| View |
DRP-10557-02-PI_01.pdf
|
DRP-10557-2
|
Meropenem (as trihydrate)
|
Merprofez 1000
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Mepromax Lifesciences Pvt. Ltd.
|
India
|
Renewal
|
25 April 2024
|
15 December 2029
|
| View |
DR-XY38938_PI_01.pdf
|
DR-XY38938
|
Montelukast (As Sodium)
|
Bronast
|
5 mg
|
Chewable Tablet
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
26 March 2021
|
11 January 2026
|
| View |
DR-XY47832_PI_01.pdf
|
DR-XY47832
|
Isavuconazonium Sulfate
|
Cresemba
|
186.3 mg Capsule
(equivalent to 100 mg Isavuconazole)
|
Capsule
|
Antifungal
|
Swissco Services AG
|
Switzerland
|
Monitored Release
|
30 March 2022
|
30 March 2027
|
| View |
|
DRP-9034-02
|
Cefepime (hydrochloride)
|
Centrapime
|
1 g
|
Powder for Injection (I.V./I.M.)
|
-
|
Union Korea Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
14 March 2023
|
13 August 2025
|
| View |
|
DRP-11662-02
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Bactisul
|
1g / 500mg
|
Powder for Injection (I.M/I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
15 November 2023
|
07 April 2027
|
| View |
|
DRP-11695-02
|
Celecoxib
|
Celenav
|
200 mg
|
Capsule
|
Anti-Inflammatory and Anti-Rheumatoid Product Non-Steroids (NSAID)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
08 November 2023
|
20 April 2027
|
| View |
|
DRP-11789-02
|
Dapagliflozin
|
Glucusuria
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (SGLT2 Inhibitor)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 November 2023
|
29 April 2027
|
| View |
|
DRP-11801-04
|
Cefuroxime (as sodium)
|
Cefucore
|
750 mg
|
|
Antibacterial (Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
02 November 2023
|
29 April 2027
|
| View |
|
DRP-12155-03
|
Atorvastatin (as Calcium Trihydrate)
|
Gostin-20
|
20 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Acme Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 November 2023
|
22 June 2027
|
| View |
|
DRP-12163-03
|
Metoclopramide (as Hydrochloride)
|
Metoden
|
5 mg / mL
|
Solution for Injection (IM/IV)
|
Propulsive
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 November 2023
|
23 June 2027
|
| View |
|
DRP-12225-01
|
Atorvastatin (as Calcium Trihydrate)
|
Atorvex-10
|
10mg
|
FIlm-Coated
|
HMG Coa Reductase Inhibitor
|
ACME Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 November 2023
|
12 July 2027
|
| View |
|
DRP-12458-02
|
Lactulose
|
Retalac
|
3.35 g/5mL
|
Oral Solution
|
Osmotically Acting Laxative
|
Panacea Biotec Pharma Limited
|
India
|
CLIDP Conversion
|
02 November 2023
|
12 August 2027
|
| View |
|
DRP-12537-02
|
Meropenem (as trihydrate)
|
Emero 1000
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Brooks Steriscience Limited
|
India
|
CLIDP Conversion
|
02 November 2023
|
31 August 2027
|
| View |
|
DRP-12591-02
|
Cefixime (as trihydrate)
|
Fixigen
|
100 mg / 5 mL (20 mg / mL)
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Private Limited
|
India
|
CLIDP Conversion
|
08 November 2023
|
19 September 2027
|